To the Editor Liver transplant (LT) has already become one of the major approaches to manage advanced liver diseases, including colorectal cancer liver metastasis (CRLM). Dueland et al1 reported their single-institutional retrospective cohort analysis on LT for CRLM, which was compared with those who received portal vein embolization (PVE) with intent to undergo liver resection (LR). Their results were seemingly encouraging but also misleading; as such, shifting treatment paradigm or making LT a new tool for patients with CRLM still remains a question to be weighed further.2,3
Aini A, Lu Q, Dong J. No Strong Evidence on Liver Transplant for Colorectal Cancer Liver Metastasis Over Portal Vein Embolization Associated With Liver Resection. JAMA Surg. 2022;157(2):172–173. doi:10.1001/jamasurg.2021.5124
Surgery in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.